Emalex Biosciences Inc.
Clinical trials sponsored by Emalex Biosciences Inc., explained in plain language.
-
New pill may help Tourette's patients keep tics in check longer
Disease control CompletedThis study tested whether a daily pill called ecopipam can help children, teens, and adults with Tourette's disorder maintain control over their tics over time. After an initial period where everyone received the drug, some participants were switched to a placebo to see if their …
Phase: PHASE3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New drug shows promise for calming Tourette's tics in kids
Symptom relief CompletedThis study tested a drug called ecopipam in 40 children aged 7 to 17 with Tourette's syndrome. The goal was to see if it could reduce the frequency and severity of their tics (unwanted movements and sounds). The drug works by blocking certain dopamine receptors in the brain. The …
Phase: PHASE2 • Sponsor: Emalex Biosciences Inc. • Aim: Symptom relief
Last updated May 26, 2026 10:07 UTC